Amal Arnaout
- Oncology top 5%
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 1
- Lung Cancer Research Studies 1
- Cancer Research top 10%
- Breast Cancer Treatment Studies 2
- Genetics top 10%
-
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Pneumonia and Respiratory Infections 1
-
- Tuberculosis Research and Epidemiology 1
-
- Statistical Methods in Clinical Trials 1
- Co-authors
- Eric P. WinerNancy U. LinJessica SohlElizabeth B. ClausHarold J. BursteinJulie NajitaErin M. OlsonSarah P. Hammond
- Partner nations
- United StatesCanada
In The Last Decade
Amal Arnaout
4 papers receiving 664 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 504
- Cancer Research 232
- Pulmonary and Respiratory Medicine 356
- Genetics 92
- Pathology and Forensic Medicine 44
Countries citing papers authored by Amal Arnaout
This map shows the geographic impact of Amal Arnaout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal Arnaout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal Arnaout more than expected).
Fields of papers citing papers by Amal Arnaout
This network shows the impact of papers produced by Amal Arnaout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal Arnaout. The network helps show where Amal Arnaout may publish in the future.
Co-authorship network
The 18 scholars most cited alongside Amal Arnaout, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 31 | |
| 2 | Neoadjuvant endocrine therapy and window of opportunity trials: new standards in the treatment of breast cancer? | 2015 | 7 |
| 3 | 2013 | 89 | |
| 4 | Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancerbreakdown → | 2008 | 546 |
About Amal Arnaout
Amal Arnaout is a scholar working on Cancer Research, Statistics and Probability and Oncology, having authored 4 papers that have together received 673 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Tuberculosis Research and Epidemiology (1 paper), Statistical Methods in Clinical Trials (1 paper), Pneumonia and Respiratory Infections (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (504 citations), Cancer Research (232 citations) and Pulmonary and Respiratory Medicine (356 citations). Amal Arnaout has collaborated with scholars based in United States and Canada. Frequent co-authors include Eric P. Winer, Nancy U. Lin, Jessica Sohl, Elizabeth B. Claus, Harold J. Burstein, Julie Najita, Erin M. Olson, Sarah P. Hammond, Sara M. Tolaney and Lindsey R. Baden. Their work appears in journals such as Cancer, Breast Cancer Research and Treatment and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.